Cargando…

More evidence for low-dose IL-2 for chronic GVHD in children

Detalles Bibliográficos
Autor principal:	Levine, John E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Inside Blood Advances
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448399/ https://www.ncbi.nlm.nih.gov/pubmed/37578812 http://dx.doi.org/10.1182/bloodadvances.2023010756

Ejemplares similares

Natalizumab for GVHD: too little or too late?
por: Quann, Kevin, et al.
Publicado: (2023)

Further evidence supporting the global use of hydroxyurea
por: Archer, Natasha M.
Publicado: (2023)

Haplo ever after: haplo PTCy for children
por: Talano, Julie-An, et al.
Publicado: (2023)

On a collision course: SARS-CoV-2 variants and CAR T cells
por: Auletta, Jeffery J.
Publicado: (2023)

Blood stem cell grafts: frozen is fine, but fresh is best
por: Horwitz, Mitchell E.
Publicado: (2023)

Small but mighty: T-replete cords for myeloid disease
por: LaBelle, James L.
Publicado: (2023)

The sweet taste of liberalizing dietary restrictions in HCT
por: Peled, Jonathan U., et al.
Publicado: (2023)

Diagnosing TMAs by automated red cell morphology analyses
por: Billett, Henny H., et al.
Publicado: (2023)

Peripheral megakaryocytes sound the alarm in COVID-19
por: Boilard, Eric, et al.
Publicado: (2023)

This CAR won’t start: predicting nonresponse in ALL
por: Webster, Jonathan A., et al.
Publicado: (2023)

Histidine-rich glycoprotein: antithrombosis without bleeding
por: Schmaier, Alvin H.
Publicado: (2023)

ADP: the missing link between thrombosis and hemolysis
por: Gerber, Gloria F., et al.
Publicado: (2023)

A wholesale approach to disarm multiple myeloma
por: Cenci, Simone
Publicado: (2023)

Autologous transplant and second malignancies in MM
por: Pasvolsky, Oren, et al.
Publicado: (2023)

It’s high time to turn the spotlight on HbSC disease
por: Oluwole, Olubusola, et al.
Publicado: (2023)

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
por: Qualls, David, et al.
Publicado: (2023)

ICANS prophylaxis: potentially transformative but elusive
por: Dowling, Mark R., et al.
Publicado: (2023)

Cord blood power and the definition of success after BMT
por: Boelens, Jaap Jan, et al.
Publicado: (2022)

Curing CLL: one clone at a time
por: Aslan, Burcu, et al.
Publicado: (2022)

HTLV-1 infection: role of CTL efficiency
por: Bangham, Charles R. M.
Publicado: (2008)

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
por: DeBaun, Michael R.
Publicado: (2020)

On the Inside
por: Minorsky, Peter V.
Publicado: (2021)

On the inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD
por: Poe, Jonathan C., et al.
Publicado: (2023)

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
por: Terpos, Evangelos, et al.
Publicado: (2021)

The management of venous thromboembolism in hospitalized patients with COVID-19
por: Spyropoulos, Alex C.
Publicado: (2020)

COVID-19 coagulopathy vs disseminated intravascular coagulation
por: Levi, Marcel
Publicado: (2020)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
por: Arruda, Valder R.
Publicado: (2021)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
por: Maillard, Alexis, et al.
Publicado: (2022)

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
por: Carsetti, Rita, et al.
Publicado: (2022)

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
por: Cappy, Pierre, et al.
Publicado: (2020)

Searching for humanity in the time of COVID
por: Tandon, Suman, et al.
Publicado: (2020)

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
por: Nickel, Robert Sheppard, et al.
Publicado: (2020)

High Efficiency BMP‐2 Coatings: Nanoscale Coatings for Ultralow Dose BMP‐2‐Driven Regeneration of Critical‐Sized Bone Defects (Adv. Sci. 2/2019)
por: Cheng, Zhe A., et al.
Publicado: (2019)

Breast Cancer: IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability (Adv. Sci. 1/2020)
por: Zhang, Lixing, et al.
Publicado: (2020)

Characterization and first‐in‐human clinical dose‐escalation safety evaluation of a next‐gen human freeze‐dried plasma
por: Cancelas, Jose A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6rkjippt9730u7lk5de9ik6oiv